NCT03321682

Brief Summary

Heart Failure is a progressive disorder that begins after an insult to the heart muscle resulting in the loss of functional cardiomyocytes, or even compromising the ability of the myocardium to contract and/or relax normally. A common finding in heart failure is exercise intolerance that generates a vicious cycle, in which the individual starts to limit his activities even further due to progressive fatigue. Studies demonstrate that regular physical exercise can increase the aerobic capacity of these individuals, delay the anaerobic threshold, and reestablish the sympathovagal balance. Paradoxically, many of these patients assume an even more sedentary lifestyle, which leads to a greater physical limitation and the progression of symptoms. Patients with heart failure present a 30% reduction in their ability to perform their daily life activities when compared to healthy individuals, and this has also been attributed to reduced muscle mass, as well as lower aerobic capacity. In this sense, strength training increases the torque and muscular endurance, capacity and functional independence, as well as the quality of life, reducing the morbidity of individuals with and without cardiovascular disease, with a lower overload to the cardiorespiratory system. It is known, however, that daily life activities require a combination of resistance and muscle strength. Aerobic training does not improve muscle strength, just as traditional strength training does not ideally represent the movements performed during daily life activities, since it does not include exercises on unstable surfaces and exercises on different axes. Functional training emerges as a simple and low cost alternative for the treatment of patients with heart failure. This method consists of integrated movements of the body, in several axes, involving joint acceleration and deceleration, stabilization, strength and neuromuscular efficiency. It aims to improve the functional capacity of the individual using exercises that relate to their specific physical activity, transferring their gains effectively to their daily lives. The aim of the present study is to evaluate the effects of functional training on cardiopulmonary capacity and quality of life in patients with heart failure, comparing it to strength training.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable heart-failure

Timeline
Completed

Started Mar 2017

Typical duration for not_applicable heart-failure

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 6, 2017

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

October 23, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 26, 2017

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2020

Completed
Last Updated

July 12, 2022

Status Verified

July 1, 2022

Enrollment Period

3.5 years

First QC Date

October 23, 2017

Last Update Submit

July 8, 2022

Conditions

Keywords

Cardiopulmonary CapacityQuality of LifeFunctional CapacityFunctional Training

Outcome Measures

Primary Outcomes (2)

  • Cardiopulmonary Capacity

    Cardiopulmonary capacity assessed by peak oxygen consumption in treadmill cardiopulmonary exercise test.

    After 12 weeks of training.

  • Quality of life

    Quality of life assessed by the Minnesota Living With Heart Failure Questionnaire. It is composed of 21 questions about limitations that are often associated with how heart failure interferes with patients' quality of life. The patient should consider the last month to answer the questions. The scale of responses for each question varies from 0 (zero) to 5, where 0 represents without limitations and 5, maximum limitation. These questions involve a physical dimension (from 1 to 7, 12 and 13 questions) that are highly interrelated with dyspnea and fatigue, an emotional dimension (17 to 21 questions) and other issues (8, 9, 10, 11, 14, 15 and 16 questions) which, added to the previous dimensions, form the total score. The scale totals 105 points. Higher values indicate maximum limitation and poorer quality of life.

    After 12 weeks of training.

Secondary Outcomes (6)

  • Functionality

    After 12 weeks of training.

  • Gait Speed

    After 12 weeks of training.

  • Palmar Grip Strength

    After 12 weeks of training.

  • Maximum Inspiratory Pressure

    After 12 weeks of training.

  • Endothelial Function

    After 12 weeks of training.

  • +1 more secondary outcomes

Study Arms (2)

Functional Training

EXPERIMENTAL

Patients in the functional training group, in addition to maintaining their usual care, will perform functional training including exercises for core strength, power training, knee dominance, hip dominance, horizontal pressure, vertical pressure, horizontal pull and vertical pull, using unstable surfaces.

Other: Functional Training

Strength Training

ACTIVE COMPARATOR

These group, in addition to maintaining their usual care, will perform the exercise protocol as recommended by the American Heart Association.

Other: Strength Training

Interventions

Exercises performed in circuit, using weights, elastic bands, suspension tapes, cones and on unstable surfaces.

Functional Training

Exercises carried out using weights and involving the main muscle groups.

Strength Training

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals resident in Porto Alegre and metropolitan area,
  • aged ≥ 18 years;
  • with diagnosis of heart failure class II and III (New York Heart Association);
  • clinically stable at least 3 months prior to the start of the study;
  • with left ventricular ejection fraction (LV) ≤ 45%;
  • under optimized pharmacological treatment;
  • with resting heart rate ˂ 120 bpm;
  • resting blood pressure ˂ 180 / 110mm Hg;
  • previously sedentary.

You may not qualify if:

  • Decompensated heart failure (evidenced by ascites, lower limb edema, jugular swelling and / or pulmonary wheezing);
  • individuals with decompensated metabolic diseases;
  • acute coronary syndrome (ACS);
  • survivors of sudden death;
  • with acute myocardial infarction (AMI) and / or cardiac surgery for less than 6 months; -
  • severe valvulopathies and / or cardiac arrhythmias;
  • presence of asymmetric septal hypertrophic cardiomyopathy with dynamic outlet obstruction;
  • with general contraindication criteria for performing the cardiopulmonary exercise test; -
  • musculoskeletal disorders that limit exercise performance;
  • with cognitive alterations that compromise the understanding of the stages and the execution of the research.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

HCPortoAlegre

Pôrto Alegre, Rio Grande do Sul, 90035- 903, Brazil

Location

Related Publications (2)

  • do Nascimento DM, Machado KC, Bock PM, Saffi MAL, Goldraich LA, Silveira AD, Clausell N, Schaan BD. Functional training improves peak oxygen consumption and quality of life of individuals with heart failure: a randomized clinical trial. BMC Cardiovasc Disord. 2023 Jul 29;23(1):381. doi: 10.1186/s12872-023-03404-7.

  • do Nascimento DM, Machado KC, Bock PM, Saffi MAL, Goldraich LA, Silveira AD, Clausell N, Schaan BD. Cardiopulmonary exercise capacity and quality of life of patients with heart failure undergoing a functional training program: study protocol for a randomized clinical trial. BMC Cardiovasc Disord. 2020 Apr 25;20(1):200. doi: 10.1186/s12872-020-01481-6.

MeSH Terms

Conditions

Heart Failure

Interventions

Resistance Training

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Beatriz D Schaan, PhD

    HCPorto Alegre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 23, 2017

First Posted

October 26, 2017

Study Start

March 6, 2017

Primary Completion

September 1, 2020

Study Completion

November 30, 2020

Last Updated

July 12, 2022

Record last verified: 2022-07

Locations